Odyssey outcomes study

Study / Research

A clinical trial led by John Kastelein that helped establish the safety and efficacy of PCSK9 inhibitors.

Mentioned in 1 video

Videos Mentioning Odyssey outcomes study

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

Peter Attia MD

A clinical trial led by John Kastelein that helped establish the safety and efficacy of PCSK9 inhibitors.